04-Sep-15 India's Dr. Reddy’s new venture capital arm is considering 20 business proposals, including a chain of dental clinics and health-diagnostic laboratories, and is likely to back one or two as part of a plan to transform India’s second-largest drug maker into a broader health-focused company. [image: Mint]
Read More
04-Sep-15 Korean medical companies will speed up their entry into China, having secured a bridgehead into the telemedicine market by inking agreements with Chinese partners. Other agreements will allow Korea to export more drugs and biotech to China. These developments will help Korea become one of the top seven healthcare powers within five years. [image: Business Korea]
Read More
03-Sep-15 Japan's medical expenses in the year to March 2015 are certain to have hit a new high above JPY40 tn (USD332 bn) because of the nation's graying population, health ministry data showed. The continuous growth also reflects advances in more expensive medical technology, while greater use of generic medicines has slowed the increase compared with previous years. [image: Getty Images].
Read More
02-Sep-15 China's economic downturn plus other factors, including overcapacity and tightening regulations, mean the next two to three years could be challenging for the foreign chemical and pharmaceutical companies located there. [image: Want China Times]
Read More
23-Aug-15 Emerging-market sales for the big pharmaceuticals firms increased by about 5.5% year over year in the second quarter, well below the 9% average of the prior four quarters. Macroeconomic pressures are increasing. Weaker currencies hurt sales, a factor put into clear focus by China’s devaluation of the yuan. [image: Nai 500]
Read MoreGGM is a research and advisory firm helping clients grow profitably in international markets.
We believe the only way to understand a market properly is on the ground. Intelligence from our in-country consultants gives you a competitive advantage in Asia, Latam, the Middle East & Africa, Europe and North America.
Our clients benefit from accurate data, reliable insights and strategic advice, giving them the confidence to make better business decisions and succeed in their global growth markets.
Successful track record in your sector since 1992
In-country research consultants in over 40 markets
Value for money - quality results at affordable rates
Work led by senior directors with >20 years experience
Proven frameworks for data analysis and strategy
Pragmatic advice based on accurate data and reliable insights
Find out more about our international market intelligence and strategy services
Get in touch to discuss your growth markets research and advisory needs:
Email: info@ggmkts.com
Follow us: